Yu Yong Insider Trades

Insider Trading History

Track insider trading activity for Yu Yong. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Genelux
Genelux GNLX
Chief Scientific Officer
Holding Value $461k 149,706 shares
Last Trade
May 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.8k 605 shares
$2.97
$3.08
Genelux
Genelux GNLX
Svp, Clinical Development
Holding Value $446k 144,938 shares
Last Trade
Mar 24, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.19k 906 shares
$2.42
$3.08
Genelux
Genelux GNLX
Svp, Clinical Development
Holding Value $449k 145,844 shares
Last Trade
Nov 17, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.23k 973 shares
$5.37
$3.08
Genelux
Genelux GNLX
Svp, Clinical Development
Holding Value $0 0 shares
Last Trade
Sep 01, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$908k 272,652 shares
$3.33
$3.08
Genelux
Genelux GNLX
Svp, Clinical Development
Holding Value $640k 207,652 shares
Last Trade
Sep 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$908k 272,652 shares
$3.33
$3.08
Genelux
Genelux GNLX
Svp, Clinical Development
Holding Value $462k 150,036 shares
Last Trade
Aug 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$490k 134,520 shares
$3.64
$3.08
Genelux
Genelux GNLX
Svp, Clinical Development
Holding Value $452k 146,817 shares
Last Trade
Aug 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.8k 3,219 shares
$3.36
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $147k 47,640 shares
Last Trade
May 12, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.3k 5,579 shares
$2.92
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $164k 53,219 shares
Last Trade
Mar 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$45.4k 13,350 shares
$3.40
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $123k 39,869 shares
Last Trade
Dec 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$89.3k 39,000 shares
$2.29
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $33.5k 10,869 shares
Last Trade
Jun 24, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.5k 6,849 shares
$2.12
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $7.7k 2,500 shares
Last Trade
May 29, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14k 5,000 shares
$2.80
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $54.6k 17,718 shares
Last Trade
Mar 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72k 11,557 shares
$6.23
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $19k 6,161 shares
Last Trade
Feb 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.7k 3,661 shares
$7.85
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $17.9k 5,803 shares
Last Trade
Dec 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$428k 32,535 shares
$13.16
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $100k 32,535 shares
Last Trade
Dec 07, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$436k 36,800 shares
$11.85
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $214k 69,335 shares
Last Trade
Nov 21, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$192k 18,665 shares
$10.26
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $271k 88,000 shares
Last Trade
Nov 20, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$164k 14,594 shares
$11.26
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $316k 102,594 shares
Last Trade
Nov 17, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$46.2k 3,541 shares
$13.04
$3.08
Genelux
Genelux GNLX
Vp, Clinical Trial Operations
Holding Value $640k 207,653 shares
Last Trade
Oct 24, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$102k 5,200 shares
$19.66
$3.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up